Naoto Wakita

2PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 20, 2026
Efficacy and Safety of Enfortumab Vedotin by Trial Eligibility in Advanced Urothelial Carcinoma: A Multicenter Real-World Study.

|Mar 14, 2026
Real-World Safety and Early Effectiveness of First-Line Enfortumab Vedotin Plus Pembrolizumab with Routine Dexamethasone Premedication in Advanced Urothelial Carcinoma.

Takuto Hara, Naoto Wakita, Taisuke Tobe

Pageof 1

Frequent Collaborators

2 joint publications

Takuto Hara

2 joint publications

Hideto Ueki

1 joint publications

Yoji Hyodo

1 joint publications

Kotaro Suzuki